Cannabix Technologies Inc.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cannabix Technologies, Inc. engages in the development and manufacturing of marijuana breathalyzer technologies for law enforcement, workplaces, and laboratories. It develops marijuana test devices to detect tetrahydrocannabinol using breath samples. The company was founded by Kulwant Malhi on April 5, 2011 and is headquartered in Burnaby, Canada.

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on June 18, 2024 in Vancouver. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors for the ensuing year, an ordinary resolution to approve the adoption of the Company's Stock Option Incentive Plan and the granting of stock options thereunder in an amount up to 15% of the total issued and outstanding shares, an ordinary resolution to approve the adoption of the Company's Restricted Share Unit Incentive Plan and the granting of equity awards thereunder in an amount up to 5% of the total issued and outstanding shares, and the election of Dr. Raj Attariwala, Dr. Phillip Olla, Rav Mlait, Bryan Loree, and Thomas Clarke as directors.

Cannabix Technologies Annual General and Special Meeting Results

VANCOUVER, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that it has entered into a strategic partnership and development agreement dated May 15, 2024 (the “Agreement”) with Omega Laboratories Inc of Ohio, USA (“Omega Laboratories” or “Omega”). The Agreement provides a pathway for commercialization of Cannabix's marijuana breathalyzer technology.

Cannabix Technologies and Omega Laboratories Inc. Enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology

VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) reports that it has entered into an arm's length marketing agreements with the following parties:

Cannabix Technologies Enters into Marketing Agreements

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safety Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safety

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers Cannabix has developed an autonomous alcohol breathalyzer screening device for employers

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors. Dr. Olla is an expert in breath technologies, breathomics, healthcare innovation, artificial and medical informatics. Dr. Olla has served as the CEO of Audacia Bioscience, a health informatics company who performed substantial work in cannabis breath research and development. Dr. Olla is one of only a handful of scientists globally who has ever conducted delta-9 THC analysis in blood and breath. Dr. Olla is an associate professor at University of Detroit Mercy in Michigan and is the Vice Chair of the MedHealth Consortium.

Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) reports that Kulwant Malhi has resigned as President and Director of the Company.

Cannabix Technologies Announces Resignation of Kulwant Malhi

VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that analysis results from the collection of breath samples from a recent “green lab” testing day in Montgomery County, Maryland were successfully analyzed (with delta9-THC detected and quantified from breath samples after smoking and edibles consumption) at a third-party location for the first time. Breath samples taken on January 3, 2024 during the Maryland green lab held by the Montgomery County Police Department were shipped to the North Louisiana Criminalistics Laboratory (“NLCL”) (Fig. 1 and Fig. 2), based in Shreveport, LA for analysis. This represents the first time, such quantification analysis, with human breath samples, collected and analyzed with Cannabix's proprietary laboratory-based marijuana detection equipment, has been successfully conducted outside of Cannabix's own labs – marking a critical step to show reproducibility of Cannabix hardware and analysis methods in multiple and independent locations.

Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab – Results Analyzed at North Louisiana Criminalistics Laboratory

VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that it has filed a provisional patent application titled, “Sample Delivery Systems and Methods for Low Volatility Analytes Obtained from Breath”. This provisional patent application covers new innovations and intellectual property related to the detection of low and semi-volatile substances (like delta-9 THC) using its proprietary Mass Spectrometer Breath Sampler (“MSBS”) technology. The MSBS is an innovative hardware device which allows for direct desorption of human breath samples into a mass spectrometer without the need for any pre-preparation (see Figure 1). The MSBS substantially simplifies laboratory analysis methods, reduces sample turnaround times (within a few minutes), and provides a truly novel method for drug screening using breath.

Cannabix Technologies Files Patent for Proprietary Laboratory Drug Analysis Device

VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”), developer of marijuana and alcohol breath testing devices, reports that it will be participating in a “green lab” testing day in Montgomery County, Maryland held by the Montgomery County Police Department. In particular the Company will be supplying its marijuana breathalyzer technology and sending its own representative to facilitate the collection of breath samples alongside law enforcement officers who are testing subjects under the influence of marijuana. The green lab is being held by the Public Safety Training Academy for the Montgomery County Police Department. Various local, regional and out of state representatives are expected to attend the event being held in early January 2024.

Cannabix Technologies to Participate in Green Lab Held by Montgomery County Police Department (Maryland)

Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles

Cannabix Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans

VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that its Mass Spectrometer Breath Sampler (“MSBS”) technology along with the Breath Collection Unit (“BCU”) have been used to quantify delta-9 THC levels from smoking and edibles in humans. This emerging capability is a significant milestone and a major leap forward in the arena of drug testing. Virtually all levels of law enforcement, government, and industry have an interest in quantifying THC levels in breath in an efficient and reliable manner which will enable the ability to correlate breath concentrations with established blood levels.

Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath

VANCOUVER, British Columbia, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that it has filed an International Patent Application (“PCT”) titled, “Apparatus and Methods for Capturing Non-Volatile and Semi-Volatile Substances from Breath”. This PCT application covers new innovations and intellectual property related the development to the detection of volatile organic compounds (VOCs) and Semi-Volatile Substances (like delta-9 THC) using the handheld Cannabix Breath Collection Unit (“BCU”). The BCU allows for the efficient collection, adsorption and desorption of analytes of low volatility from human breath.

Cannabix Technologies Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing

VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general meeting of common shareholders held on July 28, 2023 in Burnaby. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors for the ensuing year and the re-election of Rav Mlait, Dr. Raj Attariwala, Bryan Loree, Kal Malhi, and Thomas Clarke as directors.

Cannabix Technologies Annual General Meeting Results

Cannabix's MSBS Marijuana Breathalyzer Technology Detects THC in Breath after Edibles Consumption

Cannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plans

Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles. New Standards Coming for New Vehicles in the USA and Europe Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles. New Standards Coming for New Vehicles in the USA and Europe

Cannabix Technologies Creates Contactless Alcohol Breath Detection Technology for Workplace and Vehicles – New Video

Cannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Southern US Study

Cannabix Technologies to Present at Breath Summit 2022 - International Association of Breath Research (IABR)

Cannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Experimental Study

Cannabix has developed a contactless alcohol breathalyzer for vehicles. New Standards Coming for New Vehicles in the USA and Europe Cannabix has developed a contactless alcohol breathalyzer for vehicles. New Standards Coming for New Vehicles in the USA and Europe

News for Cannabix Technologies Inc. Stock (BLOZF)